Workflow
英诺特: 2024年年度权益分派实施公告

Core Viewpoint - The company, Beijing Innotech Biotechnology Co., Ltd., has announced a differentiated cash dividend distribution plan, approved at the 2024 annual shareholders' meeting, with a cash dividend of 0.56 yuan per share (including tax) [1][2]. Dividend Distribution Plan - The total share capital of the company is 136,458,196 shares, with 2,112,740 shares held in the company's repurchase account, resulting in 134,345,456 shares eligible for profit distribution [2]. - The total cash dividend to be distributed amounts to 75,233,455.36 yuan (including tax) [2]. - The cash dividend distribution will be based on the total share capital minus the shares in the repurchase account, with no stock dividends or capital reserve transfers [1][2]. Relevant Dates - The key dates for the dividend distribution are the record date, ex-dividend date, and cash dividend payment date [3]. Implementation of Distribution - The cash dividends will be distributed through the China Securities Depository and Clearing Corporation Limited, Shanghai Branch, to shareholders registered by the record date [3]. - Shares held in the company's repurchase account will not participate in this dividend distribution [3]. Taxation on Dividends - For individual shareholders holding unrestricted shares for over one year, the cash dividend is exempt from personal income tax, resulting in a net distribution of 0.56 yuan per share [4][5]. - For shares held for less than one year, the company will not withhold personal income tax at the time of distribution, but tax will be calculated upon the sale of the shares [4][5]. - Qualified Foreign Institutional Investors (QFII) will have a 10% corporate income tax withheld, leading to a net cash dividend of 0.504 yuan per share [6]. - Hong Kong investors will also have a 10% tax withheld, resulting in a net cash dividend of 0.504 yuan per share [6]. Contact Information - For inquiries regarding the dividend distribution, shareholders can contact the company's securities department at the provided phone number [7].